Literature DB >> 26149840

Challenging the use of warfarin in patients on dialysis with atrial fibrillation.

Georg Schlieper1, Jürgen Floege1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26149840     DOI： 10.1038/nrneph.2015.87

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  11 in total

1.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Soko Setoguchi; Niteesh K Choudhry
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

2.  Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.

Authors:  Georg Schlieper; Ralf Westenfeld; Thilo Krüger; Ellen C Cranenburg; Elke J Magdeleyns; Vincent M Brandenburg; Zivka Djuric; Tatjana Damjanovic; Markus Ketteler; Cees Vermeer; Nada Dimkovic; Jürgen Floege; Leon J Schurgers
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

3.  Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.

Authors:  Mitesh Shah; Meytal Avgil Tsadok; Cynthia A Jackevicius; Vidal Essebag; Mark J Eisenberg; Elham Rahme; Karin H Humphries; Jack V Tu; Hassan Behlouli; Helen Guo; Louise Pilote
Journal:  Circulation       Date:  2014-01-22       Impact factor: 29.690

4.  Anticoagulation therapy: Balancing the risks of stroke and bleeding in CKD.

Authors:  Arman Qamar; Deepak L Bhatt
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

5.  Atrial fibrillation and chronic kidney disease.

Authors:  Georg Schlieper; Thilo Krüger; Jürgen Floege
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

Review 6.  The vulnerable patient with chronic kidney disease.

Authors:  Georg Schlieper; Katharina Hess; Jürgen Floege; Nikolaus Marx
Journal:  Nephrol Dial Transplant       Date:  2015-03-04       Impact factor: 5.992

7.  Stroke and bleeding in atrial fibrillation with chronic kidney disease.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Anne-Lise Kamper; Kristine Hommel; Lars Køber; Deirdre A Lane; Jesper Lindhardsen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

8.  Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.

Authors:  Anders Nissen Bonde; Gregory Y H Lip; Anne-Lise Kamper; Peter Riis Hansen; Morten Lamberts; Kristine Hommel; Morten Lock Hansen; Gunnar Hilmar Gislason; Christian Torp-Pedersen; Jonas Bjerring Olesen
Journal:  J Am Coll Cardiol       Date:  2014-12-16       Impact factor: 24.094

9.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

Review 10.  Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients.

Authors:  Thilo Krüger; Vincent Brandenburg; Georg Schlieper; Nikolaus Marx; Jürgen Floege
Journal:  Nephrol Dial Transplant       Date:  2012-11-23       Impact factor: 5.992
View more
  2 in total

1.  Reply: Warfarin in patients on haemodialysis with atrial fibrillation—friend or foe?

Authors:  Arman Qamar; Deepak L Bhatt
Journal:  Nat Rev Nephrol       Date:  2015-07-07       Impact factor: 28.314

2.  Modulation of stroke risk in chronic kidney disease.

Authors:  Julia Arnold; Don Sims; Charles J Ferro
Journal:  Clin Kidney J       Date:  2015-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.